Metanephrine is a metabolite of the catecholamine epinephrine (adrenaline). Measuring metanephrine in plasma helps screen for pheochromocytoma and paraganglioma, rare tumors that overproduce catecholamines.
Metanephrin im Plasma is often considered in the context of tiredness, reduced capacity, brain fog, or chronic exhaustion. This short overview clarifies what the marker can contribute, where its limits are, and when symptom or illness context becomes more important.
Metanephrin im Plasma becomes relevant when low-grade inflammation, immune activity, or recovery questions are part of the picture. It can help flag inflammatory context, but it does not map symptom severity on its own.
Metanephrin im Plasma does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
Metanephrine is a substance formed when the body breaks down epinephrine (adrenaline), a hormone and neurotransmitter involved in the 'fight-or-flight' response. Plasma metanephrine testing is primarily used to aid in the diagnosis of pheochromocytoma and paraganglioma, tumors that cause excessive release of catecholamines. Because metanephrine is continuously produced by these tumors, measuring its concentration in the blood is a sensitive screening tool.
The test may be ordered when a patient has symptoms like severe high blood pressure, sweating, headaches, or a rapid heartbeat. Plasma metanephrine is often measured alongside normetanephrine for a more complete evaluation.
Low plasma metanephrine levels are generally not a concern and are not associated with specific medical conditions, as metanephrine is a byproduct of normal catecholamine metabolism. In the context of screening for pheochromocytoma, a result within the reference range (typically <0.5 nmol/L or <96 pg/mL, lab-dependent) helps exclude the tumor. Clinically, only elevated levels are considered significant.
High plasma metanephrine levels (above the lab-dependent reference range, e.g., >0.5 nmol/L or >96 pg/mL) can indicate the presence of a pheochromocytoma or paraganglioma, tumors that secrete excessive catecholamines. Certain medications, severe stress, or improper test preparation (e.g., not fasting, recent caffeine or smoking) can also cause elevated results. Because of the possibility of false positives, elevated metanephrine is usually confirmed with additional testing, such as 24-hour urine metanephrines or imaging studies.
This result is not specific for ME/CFS or Long COVID. Read it together with the clinical question, symptoms, related findings and the laboratory reference range rather than in isolation.
Practical details are separated from the general FAQ so they are easier to find.
Many labs recommend fasting for at least 8 hours and avoiding caffeine and smoking before the test, as these can affect results. The blood draw is often done while you are resting to minimize stress-induced fluctuations. Always follow your healthcare provider's specific instructions.
Metanephrin im Plasma becomes relevant when low-grade inflammation, immune activity, or recovery questions are part of the picture. It can help flag inflammatory context, but it does not map symptom severity on its own.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
You now know which questions can matter when reading this result. With Elara you can keep the value and its surrounding context together over time.
Save the lab value with its date so individual measurements do not get lost.
See previous measurements together instead of relying on a single snapshot.
View Metanephrine (Plasma) alongside symptom, energy, sleep and PEM entries without assuming one caused the other.
Export your history as a PDF — structured for the next check-up.
Normal plasma metanephrine levels are usually less than 0.5 nmol/L (approximately less than 96 pg/mL), but this can vary depending on the laboratory and testing method. It's important to interpret your result using the reference range provided by the testing lab.
High metanephrine most commonly points toward a pheochromocytoma or paraganglioma. However, it can also be elevated due to certain medications (e.g., antidepressants, decongestants), acute illness, or not following pre-test instructions. Repeat testing is often needed to rule out false positives.
Metanephrin im Plasma does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
For many fatigue-related, inflammatory, hormonal, or recovery-linked markers, interpretation becomes stronger when symptoms, exertion response, and daily function are considered together.
Metanephrin im Plasma is rarely meaningful in isolation when fatigue, brain fog, or unstable capacity are central. The fatigue hub provides the broader lab-and-symptom context.
Markers linked to sleep, stress, recovery, hormones, or metabolism often become more useful when viewed through pacing and daily load management.
Questionnaires help connect biomarkers to symptom patterns, functional limits, and patient-reported change over time.
Markers from the same system can add useful context when a single lab value is hard to interpret on its own.
No individual medical review is documented.
This English content was created with AI assistance and automatically validated. This is not an individual medical review.
This information does not replace medical advice. Lab values should be assessed in the context of your medical history, the reason for testing and other findings. Elara provides health information for orientation — not diagnoses or treatment decisions.
Bring your lab values, symptoms and energy into one shared context — so you walk into your next appointment more informed and structured.
